Your browser doesn't support javascript.
loading
iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma.
Liu, Sulai; Jiang, Jinqiong; Huang, Linsheng; Jiang, Yu; Yu, Nanhui; Liu, Xiehong; Lv, Yuan; Li, Hao; Zou, Lianhong; Peng, Chuang; Yu, Xing; Jiang, Bo.
Afiliación
  • Liu S; Department of Hepatobiliary Surgery, Hunan Research Center of Biliary Disease, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Jiang J; Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Huang L; Department of Hepatopancreatobiliary Surgery, Taihe Hospital, Hubei University of Medicine, Wuhan, Hubei, People's Republic of China.
  • Jiang Y; Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Yu N; Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Liu X; Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Lv Y; Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, People's Republic of China.
  • Li H; Department of Hepatobiliary Surgery, Hunan Research Center of Biliary Disease, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Zou L; Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Peng C; Department of Hepatobiliary Surgery, Hunan Research Center of Biliary Disease, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
  • Yu X; School of Medicine, Hunan Normal University, Changsha, People's Republic of China.
  • Jiang B; Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Cancer Manag Res ; 11: 8005-8022, 2019.
Article en En | MEDLINE | ID: mdl-31692584
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2019 Tipo del documento: Article